The role of patent waivers and compulsory licensing in facilitating access to COVID-19 vaccines: Findings from a survey among healthcare practitioners in Nigeria [PDF]
PLOS Global Public Health, 2022 The roll out of COVID-19 vaccines has again revealed the gap between high income countries and developing nations in terms of access to healthcare commodities and services. With the slow vaccination roll out in many low income countries and the emergence
Obi Peter Adigwe, Davidson Oturu
doaj +4 more sources
Importance of the intellectual property system in attempting compulsory licensing of pharmaceuticals: a cross-sectional analysis [PDF]
Globalization and Health, 2019 Background Recently, interest in compulsory licensing of pharmaceuticals has been growing regardless of a country’s income- level. We aim to investigate the use of compulsory licensing as a legitimate part of the patent system and tool for the government
Kyung-Bok Son
doaj +3 more sources
Data exclusivity exceptions and compulsory licensing to promote generic medicines in the European Union: A proposal for greater coherence in European pharmaceutical legislation [PDF]
Journal of Pharmaceutical Policy and Practice, 2017 The challenge of providing access to high-priced patented medicines is a global problem affecting all countries. A decade and a half ago the use of flexibilities contained in the World Trade Organization Agreement on Trade Related Aspects of Intellectual
Ellen F. M. ‘t Hoen +2 more
doaj +3 more sources
Compulsory licensing of pharmaceuticals during public health crisis: a TRIPS framework analysis [PDF]
Frontiers in Public HealthThe COVID-19 pandemic has exposed inequities in global healthcare resource allocation, reigniting debates over international intellectual property (IP) protections.
Zhanpeng Li, Peng Guo
doaj +2 more sources
Could international compulsory licensing reconcile tiered pricing of pharmaceuticals with the right to health? [PDF]
BMC Int Health Hum Rights, 2014 BACKGROUND: The heads of the Global Fund and the GAVI Alliance have recently promoted the idea of an international tiered pricing framework for medicines, despite objections from civil society groups who fear that this would reduce the leeway for ...
Ooms G, Forman L, Williams OD, Hill PS.
europepmc +4 more sources
Compulsory licensing and access to drugs [PDF]
The European Journal of Health Economics, 2014 Compulsory licensing allows the use of a patented invention without the owner's consent, with the aim of improving access to essential drugs. The pharmaceutical sector argues that, if broadly used, it can be detrimental to innovation. We model the interaction between a company in the North that holds the patent for a certain drug and a government in ...
Stavropoulou, C, VALLETTI, TOMMASO MARIA
openaire +7 more sources
Comment: compulsory licensing of patented pharmaceutical inventions: evaluating the options. [PDF]
J Law Med Ethics, 2009 In this Comment, the author traces the relevant legislative history pertaining to compulsory licensing of patented pharmaceuticals from the TRIPS Agreement of 1994 to the 2003 waiver to, and later proposed amendment of, article 31, which enables poor ...
Reichman JH.
europepmc +3 more sources
Trends in compulsory licensing of pharmaceuticals since the Doha Declaration: a database analysis. [PDF]
PLoS Medicine, 2012 BackgroundIt is now a decade since the World Trade Organization (WTO) adopted the "Declaration on the TRIPS Agreement and Public Health" at its 4th Ministerial Conference in Doha. Many anticipated that these actions would lead nations to claim compulsory
Reed Beall, Randall Kuhn
doaj +2 more sources
To patent or not to patent: challenges and solutions to the patent ban on new genomic techniques plant in EU [PDF]
GM Crops & FoodThe Proposal for a new Regulation on plants produced by certain new genomic techniques (NGTs) embraces the deregulation of NGT plants but introduces a patent ban on them.
Li Jiang, Mike Adcock, Hong Yang
doaj +2 more sources
Compulsory Licensing, Innovation and Welfare [PDF]
, 2013 This paper develops a three-stage model of innovation, fixed-fee licensing and production to evaluate the welfare effects of compulsory licensing, taking into account both static (information sharing) and dynamic (innovation incentive) effects. Compulsory licensing is shown to have an unambiguously positive impact on consumer surplus.
Seifert, Jacob
openaire +3 more sources